567 related articles for article (PubMed ID: 30463358)
21. [The role of TGF-β-related signal transduction pathways in pathogenesis of epithelial-mesenchymal transition as a key element in cancer development and progression].
Pieniążek M; Donizy P; Ziętek M; Szynglarewicz B; Matkowski R
Postepy Hig Med Dosw (Online); 2012 Sep; 66():583-91. PubMed ID: 23001200
[TBL] [Abstract][Full Text] [Related]
22. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
23. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
24. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
Saitoh M
Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
[TBL] [Abstract][Full Text] [Related]
26. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
27. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β.
Valcourt U; Carthy J; Okita Y; Alcaraz L; Kato M; Thuault S; Bartholin L; Moustakas A
Methods Mol Biol; 2016; 1344():147-81. PubMed ID: 26520123
[TBL] [Abstract][Full Text] [Related]
29. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor β signaling regulates the invasiveness of normal mammary epithelial cells and the metastasis formation of tumor cells.
Vafaizadeh V; Graab U; Darvishi T; Machado R; Groner B
Horm Mol Biol Clin Investig; 2012 Jun; 10(1):227-39. PubMed ID: 25436679
[TBL] [Abstract][Full Text] [Related]
31. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
[TBL] [Abstract][Full Text] [Related]
32. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.
Wendt MK; Tian M; Schiemann WP
Cell Tissue Res; 2012 Jan; 347(1):85-101. PubMed ID: 21691718
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.
Howley BV; Howe PH
Cytokine; 2019 Jun; 118():19-26. PubMed ID: 29396052
[TBL] [Abstract][Full Text] [Related]
34. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
[TBL] [Abstract][Full Text] [Related]
35. Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.
Zhao Y; Tian B; Sadygov RG; Zhang Y; Brasier AR
J Proteomics; 2016 Oct; 148():126-38. PubMed ID: 27461979
[TBL] [Abstract][Full Text] [Related]
36. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
37. Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR.
Schuhwerk H; Brabletz T
Semin Cancer Biol; 2023 Dec; 97():86-103. PubMed ID: 38029866
[TBL] [Abstract][Full Text] [Related]
38. SHON, a novel secreted protein, regulates epithelial-mesenchymal transition through transforming growth factor-β signaling in human breast cancer cells.
Li L; Liu DX; Zhang N; Liang Q; Feng J; Yao M; Liu J; Li X; Zhang Y; Lu J; Huang B
Int J Cancer; 2015 Mar; 136(6):1285-95. PubMed ID: 25082541
[TBL] [Abstract][Full Text] [Related]
39. Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
Zhou J; Jain S; Azad AK; Xu X; Yu HC; Xu Z; Godbout R; Fu Y
Cell Signal; 2016 Aug; 28(8):838-49. PubMed ID: 27075926
[TBL] [Abstract][Full Text] [Related]
40. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.
Waerner T; Alacakaptan M; Tamir I; Oberauer R; Gal A; Brabletz T; Schreiber M; Jechlinger M; Beug H
Cancer Cell; 2006 Sep; 10(3):227-39. PubMed ID: 16959614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
